AIM ImmunoTech Inc.
AIM · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,736 | $6,568 | $8,440 | $11,369 |
| - Cash | $2,347 | $476 | $898 | $1,701 |
| + Debt | $2,338 | $2,805 | $2,522 | $2,941 |
| Enterprise Value | $5,727 | $8,897 | $10,064 | $12,609 |
| Revenue | $26 | $25 | $16 | $45 |
| % Growth | 4% | 56.3% | -64.4% | – |
| Gross Profit | -$96 | $15 | $6 | $96 |
| % Margin | -369.2% | 60% | 37.5% | 213.3% |
| EBITDA | -$3,082 | -$2,590 | -$3,459 | -$5,771 |
| % Margin | -11,853.8% | -10,360% | -21,618.8% | -12,824.4% |
| Net Income | -$3,284 | -$2,794 | -$3,705 | -$5,967 |
| % Margin | -12,630.8% | -11,176% | -23,156.3% | -13,260% |
| EPS Diluted | -1,568.71 | -3.68 | -0.05 | -0.1 |
| % Growth | -42,528% | -7,260% | 50% | – |
| Operating Cash Flow | -$5,079 | -$1,531 | -$2,361 | -$3,955 |
| Capital Expenditures | $0 | -$227 | -$56 | -$119 |
| Free Cash Flow | -$5,079 | -$1,758 | -$2,417 | -$4,074 |